Evidence map›Paper›PMID 41185664›Full record

ReviewJournal of healthcare leadership2025

Artificial Intelligence in Cancer Oncology Through Comprehensive Bibliometric Mapping of Global Trends Impact and Conceptual Structures.

Rezzy Eko Caraka, Khairunnisa Supardi, Soehartati A Gondhowiardjo, Vijaya Isnaniawardhani, Prana Ugiana Gio, Rung Ching Chen, Bens Pardamean

Abstract readReview
In one paragraph

Review in Journal of healthcare leadership, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rezzy Eko CarakaEngineers Profession Program, Graduate School, Universitas Padjadjaran, Bandung, West Java, 45363, Indonesia.
Khairunnisa SupardiDepartment of Radiation Oncology, Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo National General Hospital, Jakarta, 10430, Indonesia.
Soehartati A GondhowiardjoDepartment of Radiation Oncology, Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo National General Hospital, Jakarta, 10430, Indonesia.ORCID 0000-0002-9446-4361
Vijaya IsnaniawardhaniEngineers Profession Program, Graduate School, Universitas Padjadjaran, Bandung, West Java, 45363, Indonesia.
Prana Ugiana GioDepartment of Mathematics, Universitas Sumatera Utara, Medan, Indonesia.
Rung Ching ChenDepartment of Information Management, Chaoyang University of Technology, Taichung, 41349, Taiwan.
Bens PardameanBioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, 11480, Indonesia.ORCID 0000-0002-7404-9005

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integration of artificial intelligence, particularly deep learning, has transformed cancer oncology through more precise diagnostics, personalized therapies, and improved clinical decision-making. This study conducts a bibliometric mapping to capture global research trends, intellectual influence, and conceptual structures in cancer oncology and deep learning. A total of 19,627 peer-reviewed articles published between 2022 and 2025 were analyzed, retrieved from an initial dataset of 34,218 documents. Using Correspondence Analysis (CA) and Multiple Correspondence Analysis (MCA) in RStudio, we evaluated both Author Keywords and Keyword Plus. The results highlight dominant themes, including multimodal learning and radiogenomics, while also uncovering emerging directions such as transformer-based models, federated learning for cross-institutional data, and the ethical dimensions of explainable AI in clinical workflows. MCA on Keyword Plus provided stronger explanatory power (80.01% and 8.76% for the first two dimensions) compared to CA on Author Keywords (5.27% and 3.73%). This mapping reveals critical gaps-such as limited participation from low- and middle-income countries, lack of standardized datasets, and insufficient multidisciplinary collaboration. By identifying these challenges and opportunities, the study provides actionable insights for researchers, policymakers, and clinicians to advance inclusive and ethically responsible AI-driven cancer research.

Indexed as

artificial intelligencebibliometric analysiscancer oncologydeep learningmachine learning in cancer

Identifiers

PMID41185664
PMCPMC12579864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.